Platelet Transfusion Requirements in Hematopoietic Transplantation Pilot Study
NCT02650791
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Hematologic Neoplasms
Interventions
DRUG:
Tranexamic Acid
Sponsor
Ottawa Hospital Research Institute